Are angiogenesis inhibitors in clinical trial for children with cancer?
Angiogenesis inhibitors must be tested for safety in adult cancer patients first. If a drug proves to be safe, the FDA may allow it to be tested in a clinical trial for children with cancer. At this time there are only a few angiogenesis inhibitors in clinical trial for children and these studies are limited in number and size. For information about angiogenesis inhibitors in clinical trial for children with cancer, you may consult your child’s oncologist or contact the National Cancer Institute’s Cancer Information Service at 1-800-4-CANCER (1-800-422-6237) or on the internet at http://cancernet.nci.nih.gov or http://cancertrials.nci.nih.gov.
